1. Rubin, R. Lancet 388, 1266 (2016).
2. Duhigg, C. Outcry over EpiPen prices hasn't made them lower. The New York Times (4 June 2017).
3. Kasperkevic, J. New York investigates EpiPen maker Mylan after price hike of medication. The Guardian (6 September 2016).
4. Cha, A.E. US lawmakers demand investigation of $100 price hike of lifesaving EpiPens. The Washington Post (23 August 2016).
5. US Food and Drug Administration. Approved Drug Products with Therapeutic Equivalence Evaluations 2017 (FDA, 2017).